Zobrazeno 1 - 10
of 471
pro vyhledávání: '"J. Hupfeld"'
Publikováno v:
AACE Clinical Case Reports, Vol 4, Iss 2, Pp 94-97 (2018)
ABSTRACT: Objective: Identify an endocrine developmental syndrome (DiGeorge syndrome, or 22q11 deletion syndrome) that had been previously undiagnosed in an adult patient.Methods: The patient was evaluated in an adult endocrinology clinic. In particu
Externí odkaz:
https://doaj.org/article/109cc92491c14ec494206c6ffd8f1990
Publikováno v:
Advances in Combustion Toxicology,Volume I ISBN: 9781003418948
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae1bfdd89a02d2808b5bba2ccbabb135
https://doi.org/10.1201/9781003418948-15
https://doi.org/10.1201/9781003418948-15
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 106:1235-1244
Diabetic retinopathy (DR) is a well-recognized microvascular complication of diabetes. Growing evidence suggests that, in addition to retinal vascular damage, there is significant damage to retinal neural tissue in DR. Studies reveal neuronal damage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7844f37c1efd1670327745fb2f801714
https://doi.org/10.1210/clinem/dgab050
https://doi.org/10.1210/clinem/dgab050
Publikováno v:
Current Diabetes Reports. 20
The micro/macrovascular complications of diabetes cause considerable morbidity and premature mortality. The SGLT2 inhibitors are the first diabetes medications with significant benefits on microvascular disease (nephropathy) and macrovascular cardiov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::547bd25342ea196917b1e4e8503b842e
https://doi.org/10.1007/s11892-020-01359-z
https://doi.org/10.1007/s11892-020-01359-z
Publikováno v:
AACE Clinical Case Reports, Vol 4, Iss 2, Pp 94-97 (2018)
Objective: Identify an endocrine developmental syndrome (DiGeorge syndrome, or 22q11 deletion syndrome) that had been previously undiagnosed in an adult patient.Methods: The patient was evaluated in an adult endocrinology clinic. In particular, fluor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b4a2449cf33bc0bfca3905c86a95c67
https://doi.org/10.4158/ep171882.cr
https://doi.org/10.4158/ep171882.cr
Publikováno v:
Journal of the Endocrine Society
AAA syndrome or Allgrove Syndrome is a rare autosomal recessive congenital disease characterized by the triad of adrenal insufficiency (Addison's disease), failure of the lower esophageal sphincter to relax (achalasia) and absence of tear secretion (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1cf8f950cc1e0bea01c5938480f350a
http://europepmc.org/articles/PMC6551092
http://europepmc.org/articles/PMC6551092
Publikováno v:
Diabetes, obesitymetabolism. 21(8)
The publication of results from recent cardiovascular outcome trials (CVOTs) has transformed the landscape of diabetes treatment. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium glucose co-transporter-2 (SGLT2) inhibitors have demonst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::839e3f53780450c33d9ea2dd823f8ccd
https://pubmed.ncbi.nlm.nih.gov/30957945
https://pubmed.ncbi.nlm.nih.gov/30957945
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cytotherapy. 22:S147
Background & Aim The FDA approval of Novartis‘ Kymriah and Gilead‘s Yescarta chimeric antigen receptors (CAR)-T cell products in 2017 was a landmark announcement for the cellular immunotherapy field. But despite the excitement, manufacturing of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d07259c27a0bbaab0f44e18c328bf291
https://doi.org/10.1016/j.jcyt.2020.03.298
https://doi.org/10.1016/j.jcyt.2020.03.298